Burcon Nutrascience Corporation
BU.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.55% | 61.40% | 68.36% | 70.91% | 74.52% |
| Total Depreciation and Amortization | 35.64% | 22.23% | 17.48% | 14.73% | -0.34% |
| Total Amortization of Deferred Charges | -1.47% | -0.80% | -1.08% | -1.94% | -3.64% |
| Total Other Non-Cash Items | 39.36% | -91.60% | -93.92% | -94.36% | -95.12% |
| Change in Net Operating Assets | -152.79% | -85.57% | -250.80% | 61.08% | 184.19% |
| Cash from Operations | -22.67% | -28.36% | -24.87% | 6.57% | 34.19% |
| Capital Expenditure | -68.97% | 19.90% | 26.37% | 64.74% | 56.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.64% | -3.81% | 109.67% | 102.05% | 101.78% |
| Cash from Investing | -186.29% | 24.57% | 85.67% | 99.16% | 98.77% |
| Total Debt Issued | 100.00% | -66.67% | -80.00% | -80.00% | -75.00% |
| Total Debt Repaid | -437.31% | -586.51% | -835.26% | -634.72% | 22.54% |
| Issuance of Common Stock | 31.19% | 31.19% | 27.85% | -- | 853,250.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 67.43% | 49.42% | 37.74% | -19.06% | -309.70% |
| Cash from Financing | 50.12% | -15.58% | -38.33% | 73.36% | -0.05% |
| Foreign Exchange rate Adjustments | 278.98% | -88.89% | 394.17% | -172.50% | -349.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.28% | -200.36% | -171.57% | 146.96% | 88.93% |
